» Articles » PMID: 33683568

The Role of Elabela in Kidney Disease

Overview
Publisher Springer
Specialty Nephrology
Date 2021 Mar 8
PMID 33683568
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Elabela, also known as Toddler or Apela, is a recently discovered hormonal peptide containing 32 amino acids. Elabela is a ligand of the apelin receptor (APJ). APJ is a G protein-coupled receptor widely expressed throughout body, and together with its cognate ligand, apelin, it plays an important role in various physiological processes including cardiovascular functions, angiogenesis and fluid homeostasis. Elabela also participates in embryonic development and pathophysiological processes in adulthood. Elabela is highly expressed in undifferentiated embryonic stem cells and regulates endoderm differentiation and cardiovascular system development. During differentiation, Elabela is highly expressed in pluripotent stem cells and in adult renal collecting ducts and loops, where it functions to maintain water and sodium homeostasis. Other studies have also shown that Elabela plays a crucial role in the pathogenesis of kidney diseases. This review addresses the role of Elabela in kidney diseases including renal ischemia/reperfusion injury, hypertensive nephropathy, diabetic nephropathy, and cardiorenal syndrome.

Citing Articles

Serum Elabela expression is decreased in hypertensive patients and could be associated with the progression of hypertensive renal damage.

Tian G, Zheng Q, Zhang Q, Liu X, Lu X Eur J Med Res. 2024; 29(1):94.

PMID: 38297369 PMC: 10832183. DOI: 10.1186/s40001-024-01674-1.


The Role of Apelin-APJ System in Diabetes and Obesity.

Li C, Cheng H, Adhikari B, Wang S, Yang N, Liu W Front Endocrinol (Lausanne). 2022; 13:820002.

PMID: 35355561 PMC: 8959308. DOI: 10.3389/fendo.2022.820002.


Potential Therapeutic Role for Apelin and Related Peptides in Diabetes: An Update.

Palmer E, Irwin N, OHarte F Clin Med Insights Endocrinol Diabetes. 2022; 15:11795514221074679.

PMID: 35177945 PMC: 8844737. DOI: 10.1177/11795514221074679.

References
1.
Yu X, Tang Z, Liu L, Qian H, Tang S, Zhang D . Apelin and its receptor APJ in cardiovascular diseases. Clin Chim Acta. 2013; 428:1-8. DOI: 10.1016/j.cca.2013.09.001. View

2.
Hwangbo C, Wu J, Papangeli I, Adachi T, Sharma B, Park S . Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin's glucose-lowering effects. Sci Transl Med. 2017; 9(407). PMC: 5703224. DOI: 10.1126/scitranslmed.aad4000. View

3.
Lv D, Li L, Lu Q, Li Y, Xie F, Li H . PAK1-cofilin phosphorylation mediates human lung adenocarcinoma cells migration induced by apelin-13. Clin Exp Pharmacol Physiol. 2016; 43(5):569-79. DOI: 10.1111/1440-1681.12563. View

4.
Wu L, Chen L, Li L . Apelin/APJ system: A novel promising therapy target for pathological angiogenesis. Clin Chim Acta. 2016; 466:78-84. DOI: 10.1016/j.cca.2016.12.023. View

5.
Pauli A, Norris M, Valen E, Chew G, Gagnon J, Zimmerman S . Toddler: an embryonic signal that promotes cell movement via Apelin receptors. Science. 2014; 343(6172):1248636. PMC: 4107353. DOI: 10.1126/science.1248636. View